Tata Elxsi

Tata Elxsi reported a revenue of INR 993.8 crores for Q4 FY26, achieving a 0.9% quarter-on-quarter growth in constant currency terms. The company's EBITDA margin improved by 130 basis points sequentially to 24.6%, reflecting a focus on operational excellence and margin improvement. This performance was supported by currency tailwinds and operating efficiencies, with the utilization rate standing at 73%.

The Transportation business grew by 0.2% QoQ in constant currency, securing two strategic wins, including a new-age OEM in APAC and a next-gen mobility services company in the US. The Media and Communication business showed strong growth of 5.6% QoQ in constant currency, driven by deal ramp-ups and a multi-year large deal win. However, the Healthcare and Life Sciences vertical de-grew significantly by 13.1% QoQ in constant currency due to unexpected delays in deal awards, though management expects recovery in Q1 FY27 as some deals have already closed post-quarter.

Tata Elxsi is progressing towards becoming an AI-native engineering organization, leveraging GenAI for both internal efficiencies and client solutions. While GenAI conversations are more prevalent in Media and Telecom for efficiency and budget management, in Automotive and Healthcare, the focus is on addressing cybersecurity, confidentiality, and regulatory requirements. Management noted that GenAI can improve productivity and pricing power, but also emphasized the need for custom tools in regulated industries, such as their DevStudio.ai platform for automotive.

The 130 basis points sequential improvement in EBITDA margin was primarily driven by 150-155 bps from currency tailwinds and 65 bps from operating efficiencies, including pyramid optimization and better management of fixed-price contracts. Utilization improved to 73%, contributing to margin gains. The company aims for a 27% PBT margin by Q4 FY27, indicating a sustained but gradual effort towards margin expansion, tightly aligned with top-line growth.

New customers contribute a smaller portion (2-2.5%) of revenue, with the majority coming from existing client expansion. Deal closures, particularly in Healthcare, faced delays, pushing some expected wins from Q4 to Q1, which had been in the pipeline since October. The company continues to pursue large, multi-million dollar deals, some of which are fixed-price contracts, but management exercises caution due to execution risks, emphasizing that shifting too much business to fixed-price is not advisable.

Due to current geopolitical uncertainties and mixed market conditions, Tata Elxsi has revised its overall FY27 revenue growth aspiration from a previous double-digit target to a 'higher single digit.' The automotive segment is also expected to achieve a 'high-single digit exit' for FY27, rather than double-digit growth. This conservative outlook reflects the current visibility, ongoing conversations with customers, and the deals being pursued.

Tata Elxsi is actively investing in new growth areas such as aerospace and defense, battery energy storage, and manufacturing. The company is building capabilities, winning initial projects, and expects one or two of these new verticals to start showing results within the next four to six quarters. This strategic focus aims to build muscle and strength in these areas, contributing to future diversification and growth.